Purity, activity, and virus safety of a pasteurized antithrombin concentrate

被引：6
|
作者：
Gröner, A
Nowak, T
Römisch, J
机构：
[1] Aventis Behring GmbH, D-35002 Marburg, Germany
[2] Res Labs Aventis Behring GmbH, Marburg, Germany
来源：
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2002年 / 28卷
关键词：
D O I：
10.1055/s-2002-30200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：79 / 85
页数：7
相关论文
共 50 条
  • [21] Dosing and safety of antithrombin concentrate in pediatric patients who require heparin anticoagulation
    Bauman, M. E.
    Black, K. L.
    Bruce, A.
    Kuhle, S.
    Bajzar, L.
    Massicotte, M. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1111 - 1111
  • [22] INTRODUCTION OF A NEW FACTOR-VIII CONCENTRATE COMBINING THE DESIRABLE QUALITIES OF PATHOLOGICAL VIRUS SAFETY WITH HIGH-PURITY
    SMITH, AD
    RICERCA IN CLINICA E IN LABORATORIO, 1986, 16 (01): : 219 - 220
  • [23] From cryoprecipitate to virus-safe high-purity concentrate
    Heimburger, N
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 : 25 - 29
  • [24] Pathogen safety of a pasteurized four-factor human prothrombin complex concentrate preparation using serial 20N virus filtration
    Nowak, Thomas
    Popp, Birgit
    Groener, Albrecht
    Schaefer, Wolfram
    Kalina, Uwe
    Enssle, Karlheinz
    Roth, Nathan J.
    TRANSFUSION, 2017, 57 (05) : 1184 - 1191
  • [25] Review of the Long-Term Safety of a Human Pasteurized C1 Inhibitor Concentrate
    Bork, K.
    Korger, G.
    Kreuz, W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB222 - AB222
  • [26] Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency An update
    Rodgers, George M.
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (05) : 806 - 812
  • [27] Two dimensional gel electrophoresis of human antithrombin III concentrate double virus inactivated
    Arrighi, S
    Del Carlo, M
    Maggianetti, S
    Morelli, A
    THROMBOSIS AND HAEMOSTASIS, 1999, : 570 - 570
  • [28] Safety of solvent detergent viral inactivated intermediate purity factor VIII concentrate
    Shaw-Schwyzer, R.
    Mbele, B.
    Gillham, A.
    HAEMOPHILIA, 2010, 16 : 39 - 39
  • [29] A retrospective survey on the safety of Replenate®, a high-purity factor VIII concentrate
    Gascoigne, EW
    Dash, CH
    Harman, C
    Wilmot, D
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (04) : 243 - 252
  • [30] A retrospective survey on the safety of Replenine®, a high-purity factor IX concentrate
    Gascoigne, EW
    Dash, CH
    Harman, C
    Wilmot, D
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (03) : 187 - 195
12345